U.S. pharma big copyright scrapped two experimental weight loss capsules past yr—a at the time-every day pill, lotiglipron, as a consequence of elevated liver enzymes as well as a two times-day by day capsule, danuglipron, due to solid side effects—but CEO Albert Bourla has mentioned the company is determined to “play and get” from the weig